T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
United Kingdom
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
France
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Spain
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Germany
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Czech Republic
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Switzerland
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Belgium
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Austria
18175738.6
Filed on 2018-06-04
18175738.6
Filed on 2018-06-04
Fully Human Antibody Binders To Human CD22 For CAR-T Therapeutics Development
China
201880080739.4
Filed on 2018-10-16
201880080739.4
Filed on 2018-10-16
INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS
Patent Cooperation Treaty
PCT/US2020/060955
Filed on 2020-11-18
PCT/US2020/060955
Filed on 2020-11-18